SEC Form 4 · accession 0001128732-16-000036
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve N. Slilaty
Officer — Chief Executive Officer · Director
Period of report
Dec 6, 2016
Accepted (ET)
Dec 15, 2016 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 6, 2016 | A | 26,000,000 | $0.001 | A | 38,384,373 | D |
Table II — derivative securities
No Table II lines on this filing.